← Leaderboards
Jun-Xu Li
State University Of New York At Buffalo
$5,236,253
Attributed
$6,490,747
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2013–23$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,490,747 · 5
By mechanism
R01$3,665,961 · 2
R61$1,881,741 · 1
R21$943,045 · 2
Top collaborators
- Yuan-Xiang Tao1 shared
- Yanan Zhang1 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Gregory A Fabiano$8,225,343
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseReceptorRattusPharmacotherapyMissionAgonistMediatingPharmaceutical PreparationsFemaleBehaviorMaleIntravenousSelf AdministrationUnited States National Institutes Of HealthAddictionMechanicsAcuteInfusion ProceduresBehavioralFda ApprovedBaseCombatDrug AddictionInvestigation
Grant awards (16)
Development of LPA5 Antagonists as Analgesics$1,881,741
R61 · FY2023 · NS
TAAR1 agonists for nicotine addiction$395,454
R01 · FY2023 · DA · contact PI
TAAR1 agonists for nicotine addiction$394,905
R01 · FY2022 · DA · contact PI
TAAR1 agonists for nicotine addiction$394,375
R01 · FY2021 · DA · contact PI
TAAR1 agonists for nicotine addiction$393,860
R01 · FY2020 · DA · contact PI
TAAR1 agonists for nicotine addiction$407,489
R01 · FY2019 · DA · contact PI
Imidazoline I2 receptors as targets for the treatment of pain$367,757
R01 · FY2017 · DA · contact PI
TAAR 1 modulation of addiction-related effects of nicotine$212,155
R21 · FY2017 · DA · contact PI
Imidazoline I2 receptors as targets for the treatment of pain$319,613
R01 · FY2016 · DA · contact PI
TAAR 1 modulation of addiction-related effects of nicotine$267,044
R21 · FY2016 · DA · contact PI
IMIDAZOLINE I2 RECEPTORS AS TARGETS FOR THE TREATMENT OF PAIN$18,607
R01 · FY2016 · DA · contact PI
Imidazoline I2 receptors as targets for the treatment of pain$317,750
R01 · FY2015 · DA · contact PI
Imidazoline I2 receptors as targets for the treatment of pain$322,346
R01 · FY2014 · DA · contact PI
Behavioral effects of methamphetamine & imidazoline I2 receptor ligands$204,775
R21 · FY2014 · DA · contact PI
Imidazoline I2 receptors as targets for the treatment of pain$333,805
R01 · FY2013 · DA · contact PI
Behavioral effects of methamphetamine & imidazoline I2 receptor ligands$259,071
R21 · FY2013 · DA · contact PI